使用环素与塔克罗利斯的免疫抑制显示了脏区内独特的毒性概况
Hasan Demirci1,2, Suncica Popovic1, Carsten Dittmayer3
1Institute of Functional Anatomy, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Acta physiologica (Oxford, England)
|June 17, 2024
概括
氨酸抑制剂 (CNIs),如环素A和塔克罗利,对移植接受者造成差异性损伤. 塔克罗利斯主要损害血管系统,而环素A影响管道,指导未来的CNI选择.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫抑制是一种免疫抑制.
- 移植生物学 移植生物学
背景情况:
- 氨酸抑制剂 (CNIs) 对于预防移植排斥是必不可少的.
- 然而,像环素A (CsA) 和塔克罗利 (Tac) 这样的CNI会引起毒性,导致移植损伤.
- 了解差异性腔损伤对于优化免疫抑制至关重要.
研究的目的:
- 调查慢性CsA和Tac暴露对 compartments 的明显影响.
- 在不可逆转的损伤发生之前,确定 CNI 诱导的毒性背后的分子机制.
主要方法:
- 长期给予CsA和Tac给Wistar大鼠,持续4周.
- 使用电子显微镜和先进光显微镜技术进行组织病理学分析.
- 通过RNA-seq和蛋白质组学进行分子分析,在人类脏活检中得到验证.
主要成果:
- 塔克主要损害了淋巴细胞过屏障,通过VEGF/VEGFR2信号传递影响内皮和细胞.
- CsA主要损坏了近接管上皮质,导致溶酶体功能障碍,亡和氧化应激.
- 在人类样本中观察到并证实了不同的病变特征.
结论:
- 区的致病基因变化是CsA或Tac治疗的特征.
- 在临床实践中,CNI的选择应该考虑个体患者对血管损伤和管道损伤的风险.
- 识别的蛋白质签名可能有助于诊断CNI特异性毒性.
相关概念视频
Drug Elimination by Renal Route: Tubular Secretion
2.3K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.3K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Renal Drug Excretion: Tubular Secretion
174
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
174
Tissue-Drug Binding: Localization of Drugs and its Significance
77
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
77
Pulmonary Tuberculosis I
231
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
231


